Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study.
Groenland SL, van Eerden RAG, Westerdijk K, Meertens M, Koolen SLW, Moes DJAR, de Vries N, Rosing H, Otten H, Vulink AJE, Desar IME, Imholz ALT, Gelderblom H, van Erp NP, Beijnen JH, Mathijssen RHJ, Huitema ADR, Steeghs N; Dutch Pharmacology Oncology Group (DPOG). Groenland SL, et al. Among authors: meertens m. Ann Oncol. 2022 Oct;33(10):1071-1082. doi: 10.1016/j.annonc.2022.06.010. Epub 2022 Jun 28. Ann Oncol. 2022. PMID: 35777707 Free article.
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature.
van Berge Henegouwen JM, van der Wijngaart H, Zeverijn LJ, Hoes LR, Meertens M, Huitema ADR, Devriese LA, Labots M, Verheul HMW, Voest EE, Gelderblom H. van Berge Henegouwen JM, et al. Among authors: meertens m. Cancer Chemother Pharmacol. 2022 Jul;90(1):97-104. doi: 10.1007/s00280-022-04437-z. Epub 2022 May 22. Cancer Chemother Pharmacol. 2022. PMID: 35598186 Free PMC article. Review.
Age and fast initial response predict omalizumab retreatment in chronic urticaria.
Meertens MAJ, Luijf T, van Lindonk EAM, Soegiharto R, Assil S, Alizadeh Aghdam M, Kentie PA, Knulst AC, van Doorn MBA, Röckmann H. Meertens MAJ, et al. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3556-3558.e1. doi: 10.1016/j.jaip.2023.07.030. Epub 2023 Jul 28. J Allergy Clin Immunol Pract. 2023. PMID: 37517795 Free article. No abstract available.
Femoral or Radial Secondary Access in TAVR: A Subanalysis From the Multicenter PULSE Registry.
Grundmann D, Kim W, Kellner C, Adam M, Braun D, Tamm AR, Meertens M, Hamm CW, Bleiziffer S, Gmeiner J, Sedaghat A, Leistner D, Renker M, Wienemann H, Charitos E, Linnemann M, Zapustas N, Juri B, Salem M, Dreger H, Goßling A, Nahif A, Conradi L, Schofer N, Schäfer A, Popara J, Sudo M, Potratz M, Geyer M, Vorpahl M, Frank D, Rudolph TK, Seiffert M. Grundmann D, et al. Among authors: meertens m. JACC Cardiovasc Interv. 2024 Dec 23;17(24):2923-2932. doi: 10.1016/j.jcin.2024.09.020. JACC Cardiovasc Interv. 2024. PMID: 39722273 Free article.
Impact of Measured and Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement.
Guthoff H, Abdel-Wahab M, Kim WK, Witberg G, Wienemann H, Thurow M, Shamekhi J, Eckel C, von der Heide I, Veulemans V, Landt M, Barbanti M, Finkelstein A, Schewel J, Van Mieghem N, Adrichem R, Toggweiler S, Rheude T, Nombela-Franco L, Amat-Santos IJ, Ruile P, Estévez-Loureiro R, Bunc M, Branca L, De Backer O, Tarantini G, Mylotte D, Arzamendi D, Pauly M, Bleiziffer S, Renker M, Al-Kassou B, Möllmann H, Ludwig S, Zeus T, Tamburino C, Schmidt T, Rück A, von Stein P, Thiele H, Abdelhafez A, Adam M, Baldus S, Rudolph T, Mauri V; IMPPACT TAVR Investigators. Guthoff H, et al. JACC Cardiovasc Interv. 2024 Nov 25;17(22):2626-2635. doi: 10.1016/j.jcin.2024.08.041. JACC Cardiovasc Interv. 2024. PMID: 39603776 Free article.
Pretreatment With Unfractionated Heparin in ST-Elevation Myocardial Infarction—a Propensity Score Matching Analysis.
Macherey-Meyer S, Heyne S, Meertens MM, Finke K, Mauri V, Ahrens I, Baer FM, Eberhardt F, Horlitz M, Sinning JM, Meissner A, Rosswinkel B, Baldus S, Adler C, Lee S; KIM e.V.. Macherey-Meyer S, et al. Among authors: meertens mm. Dtsch Arztebl Int. 2024 Dec 27;(Forthcoming):arztebl.m2024.0212. doi: 10.3238/arztebl.m2024.0212. Online ahead of print. Dtsch Arztebl Int. 2024. PMID: 39475751 Free article.
48 results